191 related articles for article (PubMed ID: 27289213)
1. Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis.
Buchy L; Mathalon DH; Cannon TD; Cadenhead KS; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Addington J
Psychiatry Res Neuroimaging; 2016 Aug; 254():3-9. PubMed ID: 27289213
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis.
Buchy L; Cannon TD; Anticevic A; Lyngberg K; Cadenhead KS; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
BMC Psychiatry; 2015 Nov; 15():276. PubMed ID: 26553191
[TBL] [Abstract][Full Text] [Related]
3. Impact of cannabis use on thalamic volume in people at familial high risk of schizophrenia.
Welch KA; Stanfield AC; McIntosh AM; Whalley HC; Job DE; Moorhead TW; Owens DG; Lawrie SM; Johnstone EC
Br J Psychiatry; 2011 Nov; 199(5):386-90. PubMed ID: 21903664
[TBL] [Abstract][Full Text] [Related]
4. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
[TBL] [Abstract][Full Text] [Related]
5. Cortical thinness and volume differences associated with marijuana abuse in emerging adults.
Mashhoon Y; Sava S; Sneider JT; Nickerson LD; Silveri MM
Drug Alcohol Depend; 2015 Oct; 155():275-83. PubMed ID: 26249265
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis.
Buchy L; Seidman LJ; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Stone W; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
Psychiatry Res; 2015 Dec; 230(3):878-84. PubMed ID: 26626949
[TBL] [Abstract][Full Text] [Related]
7. Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users.
Schacht JP; Hutchison KE; Filbey FM
Neuropsychopharmacology; 2012 Oct; 37(11):2368-76. PubMed ID: 22669173
[TBL] [Abstract][Full Text] [Related]
8. Cannabis use in patients with early psychosis is associated with alterations in putamen and thalamic shape.
Sami M; Cole JH; Kempton MJ; Annibale L; Das D; Kelbrick M; Eranti S; Collier T; Onyejiaka C; O'Neill A; Lythgoe DJ; McGuire P; Williams SCR; Bhattacharyya S
Hum Brain Mapp; 2020 Oct; 41(15):4386-4396. PubMed ID: 32687254
[TBL] [Abstract][Full Text] [Related]
9. Abnormal relationships between local and global brain measures in subjects at clinical high risk for psychosis: a pilot study.
Konishi J; Del Re EC; Bouix S; Blokland GAM; Mesholam-Gately R; Woodberry K; Niznikiewicz M; Goldstein J; Hirayasu Y; Petryshen TL; Seidman LJ; Shenton ME; McCarley RW
Brain Imaging Behav; 2018 Aug; 12(4):974-988. PubMed ID: 28815390
[TBL] [Abstract][Full Text] [Related]
10. Craving is associated with amygdala volumes in adolescent marijuana users during abstinence.
Padula CB; McQueeny T; Lisdahl KM; Price JS; Tapert SF
Am J Drug Alcohol Abuse; 2015 Mar; 41(2):127-32. PubMed ID: 25668330
[TBL] [Abstract][Full Text] [Related]
11. Reduced amygdala and hippocampal volumes in patients with methamphetamine psychosis.
Orikabe L; Yamasue H; Inoue H; Takayanagi Y; Mozue Y; Sudo Y; Ishii T; Itokawa M; Suzuki M; Kurachi M; Okazaki Y; Kasai K
Schizophr Res; 2011 Nov; 132(2-3):183-9. PubMed ID: 21784619
[TBL] [Abstract][Full Text] [Related]
12. Substance use in individuals at clinical high risk of psychosis.
Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Heinssen R; Bearden CE; Mathalon D; Addington J
Psychol Med; 2015 Aug; 45(11):2275-84. PubMed ID: 25727300
[TBL] [Abstract][Full Text] [Related]
13. Subcortical Brain Volume Abnormalities in Individuals With an At-risk Mental State.
Sasabayashi D; Takayanagi Y; Takahashi T; Katagiri N; Sakuma A; Obara C; Katsura M; Okada N; Koike S; Yamasue H; Nakamura M; Furuichi A; Kido M; Nishikawa Y; Noguchi K; Matsumoto K; Mizuno M; Kasai K; Suzuki M
Schizophr Bull; 2020 Jul; 46(4):834-845. PubMed ID: 32162659
[TBL] [Abstract][Full Text] [Related]
14. Hippocampal subfield and amygdala nuclei volumes in schizophrenia patients with a history of violence.
Tesli N; van der Meer D; Rokicki J; Storvestre G; Røsæg C; Jensen A; Hjell G; Bell C; Fischer-Vieler T; Tesli M; Andreassen OA; Melle I; Agartz I; Haukvik UK
Eur Arch Psychiatry Clin Neurosci; 2020 Sep; 270(6):771-782. PubMed ID: 31980898
[TBL] [Abstract][Full Text] [Related]
15. Amygdala subnucleus volumes in psychosis high-risk state and first-episode psychosis.
Armio RL; Laurikainen H; Ilonen T; Walta M; Salokangas RKR; Koutsouleris N; Hietala J; Tuominen L
Schizophr Res; 2020 Jan; 215():284-292. PubMed ID: 31744752
[TBL] [Abstract][Full Text] [Related]
16. Regional brain abnormalities associated with long-term heavy cannabis use.
Yücel M; Solowij N; Respondek C; Whittle S; Fornito A; Pantelis C; Lubman DI
Arch Gen Psychiatry; 2008 Jun; 65(6):694-701. PubMed ID: 18519827
[TBL] [Abstract][Full Text] [Related]
17. Hippocampal structural alterations in early-stage psychosis: Specificity and relationship to clinical outcomes.
Brunner G; Gajwani R; Gross J; Gumley AI; Krishnadas R; Lawrie SM; Schwannauer M; Schultze-Lutter F; Fracasso A; Uhlhaas PJ
Neuroimage Clin; 2022; 35():103087. PubMed ID: 35780662
[TBL] [Abstract][Full Text] [Related]
18. Shared Predisposition in the Association Between Cannabis Use and Subcortical Brain Structure.
Pagliaccio D; Barch DM; Bogdan R; Wood PK; Lynskey MT; Heath AC; Agrawal A
JAMA Psychiatry; 2015 Oct; 72(10):994-1001. PubMed ID: 26308883
[TBL] [Abstract][Full Text] [Related]
19. Altered Thalamo-Cortical White Matter Connectivity: Probabilistic Tractography Study in Clinical-High Risk for Psychosis and First-Episode Psychosis.
Cho KI; Shenton ME; Kubicki M; Jung WH; Lee TY; Yun JY; Kim SN; Kwon JS
Schizophr Bull; 2016 May; 42(3):723-31. PubMed ID: 26598740
[TBL] [Abstract][Full Text] [Related]
20. Stress-induced cortical dopamine response is altered in subjects at clinical high risk for psychosis using cannabis.
Schifani C; Pruessner J; Tseng HH; Rao N; Tagore A; Wilson AA; Houle S; Rusjan PM; Mizrahi R
Addict Biol; 2020 Jul; 25(4):e12812. PubMed ID: 31389139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
